A detailed history of National Bank Of Canada transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 21,216 shares of CRL stock, worth $4.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,216
Previous 21,216 -0.0%
Holding current value
$4.2 Million
Previous $4.18 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$187.96 - $245.29 $1.25 Million - $1.63 Million
6,627 Added 45.42%
21,216 $4.18 Million
Q2 2024

Aug 02, 2024

SELL
$206.39 - $268.73 $5.8 Million - $7.55 Million
-28,089 Reduced 65.82%
14,589 $3.01 Million
Q1 2024

May 13, 2024

SELL
$203.52 - $273.43 $12.4 Million - $16.7 Million
-61,096 Reduced 58.87%
42,678 $11.6 Million
Q4 2023

Feb 06, 2024

SELL
$164.52 - $238.84 $3.07 Million - $4.46 Million
-18,681 Reduced 15.26%
103,774 $24.5 Million
Q3 2023

Oct 10, 2023

BUY
$194.44 - $217.61 $8.1 Million - $9.07 Million
41,662 Added 51.57%
122,455 $24 Million
Q2 2023

Jul 26, 2023

SELL
$183.71 - $210.25 $1.44 Million - $1.65 Million
-7,859 Reduced 8.87%
80,793 $17 Million
Q1 2023

Apr 12, 2023

SELL
$191.89 - $259.92 $2.63 Million - $3.56 Million
-13,711 Reduced 13.39%
88,652 $17.9 Million
Q4 2022

Jan 24, 2023

BUY
$197.11 - $250.07 $10.1 Million - $12.8 Million
51,321 Added 100.55%
102,363 $0
Q3 2022

Oct 13, 2022

BUY
$182.44 - $250.54 $560,090 - $769,157
3,070 Added 6.4%
51,042 $10.4 Million
Q2 2022

Jul 28, 2022

BUY
$204.13 - $302.4 $303,541 - $449,668
1,487 Added 3.2%
47,972 $10.5 Million
Q1 2022

May 05, 2022

BUY
$255.51 - $362.11 $11.4 Million - $16.1 Million
44,519 Added 2264.45%
46,485 $13.8 Million
Q4 2021

Jan 24, 2022

BUY
$351.38 - $448.68 $690,813 - $882,104
1,966 New
1,966 $688,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.